1887

Abstract

The aim of the current study was to assess the reliability of two enzyme immunoassays in detecting the status of stool specimens of Turkish dyspeptic patients in the post-treatment period. Forty-eight patients with non-ulcer dyspepsia who were positive for underwent a 1 week regimen of triple therapy. Stool samples of patients were obtained 2 and 6 weeks after eradication therapy and a [C]urea breath test was performed 6 weeks after therapy in order to assess the reliability of mAb-based (Amplified IDEIA HpStAR, DakoCytomation) and polyclonal-antiserum-based (Premier Platinum HpSA, Meridian Diagnostics) stool antigen test kits and to compare their diagnostic accuracies. Using a minimum cutoff OD value of 0.19 for Amplified IDEIA HpStAR and 0.16 for Premier Platinum HpSA the sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of the tests were determined 2 and 6 weeks after completion of eradication therapy. At both the second and the sixth week in the post-treatment period the diagnostic accuracy of Amplified IDEIA HpStAR was significantly better than the Premier Platinum's (75 % versus 50 %, S = 6.4; = 0.011, and 90 % versus 69 %, S = 6.316; = 0.012, respectively). In light of these findings the mAb-based Amplified IDEIA HpStAR has a high diagnostic accuracy for infection in Turkish dyspeptic patients 6 weeks after completion of eradication therapy.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45914-0
2005-09-01
2024-11-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/9/JM540909.html?itemId=/content/journal/jmm/10.1099/jmm.0.45914-0&mimeType=html&fmt=ahah

References

  1. Agha-Amiri K., Peitz U., Mainz D., Kahl S., Leodolter A., Malfertheiner P. 2001; A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool. Z Gastroenterol 39:555–560 [CrossRef]
    [Google Scholar]
  2. Bilardi C., Biagini R., Dulbecco P. & 9 other authors; 2002; Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 16:1733–1738 [CrossRef]
    [Google Scholar]
  3. Cadranel S., Corvaglia L., Bontems P., Deprez C., Glupczynski Y., Van Riet A., Keppens E. 1998; Detection of Helicobacter pylori infection in children with a standardized and simplified 13C-urea breath test. J Pediatr Gastroenterol Nutr 27:275–280 [CrossRef]
    [Google Scholar]
  4. Forne M., Dominguez J., Fernandez-Banares F., Lite J., Esteve M., Gali N., Espinos J. C., Quintana S., Viver J. M. 2000; Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up. Am J Gastroenterol 95:2200–2205 [CrossRef]
    [Google Scholar]
  5. Gisbert J. P., Pajares J. M. 2004; Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter 9:347–368 [CrossRef]
    [Google Scholar]
  6. Makristathis A., Barousch W., Pasching E., Binder C., Kuderna C., Apfalter P., Rotter M. L., Hirschl A. M. 2000; Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. J Clin Microbiol 38:3710–3714
    [Google Scholar]
  7. Malfertheiner P., Megraud F., O'Morain C., Hungin A. P., Jones R., Axon A., Graham D. Y., Tytgat G. the European Helicobacter Pylori Study Group (EHPSG) (2002) Current concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report. Aliment Pharmacol Ther 16:167–180
    [Google Scholar]
  8. Marshall B. J., Warren J. R. 1984; Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315
    [Google Scholar]
  9. Odaka T., Yamaguchi T., Koyama H., Saisho H., Nomura F. 2002; Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. Am J Gastroenterol 97:594–599 [CrossRef]
    [Google Scholar]
  10. Parkin D. M., Laara E., Muir C. S. 1988; Estimates of worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–197 [CrossRef]
    [Google Scholar]
  11. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. 1991; Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131 [CrossRef]
    [Google Scholar]
  12. Selimoglu M. A., Ertekin V., Inandi T. 2002; Seroepidemiology of Helicobacter pylori infection in children living in eastern Turkey. Pediatr Int 44:666–669 [CrossRef]
    [Google Scholar]
  13. Trevisani L., Sartori S., Galvani F., Rossi M. R., Ruina M., Chiamenti C., Caselli M. 1999; Evaluation of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospective pilot study. Am J Gastroenterol 94:1830–1833 [CrossRef]
    [Google Scholar]
  14. Us D., Hascelik G. 1998; Seroprevalence of Helicobacter pylori infection in an asymptomatic Turkish population. J Infect 37:148–150 [CrossRef]
    [Google Scholar]
  15. Vaira D., Malfertheiner P., Megraud F. & 7 other authors; 2000; Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study.The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol 95:925–929 [CrossRef]
    [Google Scholar]
  16. Weingart V., Russmann H., Koletzko S., Weingart J., Hochter W., Sackmann M. 2004; Sensitivity of a novel stool antigen test for detection of Helicobacter pylori in adult outpatients before and after eradication therapy. J Clin Microbiol 42:1319–1321 [CrossRef]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.45914-0
Loading
/content/journal/jmm/10.1099/jmm.0.45914-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error